ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,098, issued on Nov. 25, was assigned to AAVATAR THERAPEUTICS Co. LTD. (Gyeonggi-Do, South Korea).
"Adeno-associated virus variant" was invented by Dong Woo Song (Seoul, South Korea) and Hyekyung Oh (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an AAV variant, for example, an AAV2 variant. An AAV variant according to some embodiments of the present disclosure comprises a VP1 variant comprising having any one amino acid sequence selected from SEQ ID NOS: 02 to 31."
The patent was filed on Feb. 13, 2025, under Application No. 19/052,822.
*For further information, including images, charts and tabl...